Menup Max (Sildenafil)

Sildenafil acts on the nitric‑oxide/cGMP pathway to address erectile dysfunction.

• Erectile dysfunction: improves ability to achieve and maintain an erection sufficient for sexual activity.

• Sildenafil selectively inhibits the enzyme phosphodiesterase type 5 (PDE5) in the corpus cavernosum. By blocking PDE5, it prevents the breakdown of cyclic guanosine monophosphate (cGMP), allowing cGMP levels to rise. Elevated cGMP leads to smooth‑muscle relaxation and increased blood flow to penile tissue, facilitating erection in response to sexual stimulation.

Sildenafil may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Headache: mild to moderate pain often resolving without treatment.
• Flushing: warmth and redness of the face or upper body.
• Dyspepsia: indigestion or upset stomach.
• Nasal congestion: stuffy or runny nose.
• Visual disturbances: blurred vision or color tinge.
• Back pain: muscular discomfort, usually temporary.

Serious or Rare Side Effects

• Priapism: prolonged erection lasting more than four hours requiring medical attention.
• Sudden vision loss: abrupt loss of vision in one or both eyes.
• Sudden hearing loss: unexpected loss of hearing or ringing in the ears.
• Myocardial infarction: heart attack in patients with cardiovascular risk.
• Stroke: cerebrovascular event, particularly in high‑risk individuals.
• Severe hypotension: marked drop in blood pressure causing dizziness or fainting.

Before prescribing Menup Max, consider the following precautions to ensure safe use.

• Cardiovascular assessment: evaluate patients with recent heart attack, uncontrolled angina, or severe heart failure.
• Concomitant nitrate therapy: avoid use with nitrates due to risk of severe hypotension.
• Visual disorders: caution in patients with retinitis pigmentosa or other retinal diseases.
• Blood pressure monitoring: monitor in patients with hypertension or on antihypertensive drugs.
• Drug interactions: review all concurrent medications for potential interactions.
• Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture and light.

Sildenafil can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Nitrates (e.g., nitroglycerin, isosorbide dinitrate): may cause profound hypotension.
• Guanylate cyclase stimulators (e.g., riociguat): risk of excessive blood pressure lowering.
• Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin): increase sildenafil exposure.
• Alpha‑blockers (e.g., doxazosin) in high doses: may lead to symptomatic hypotension.
• Other PDE5 inhibitors (e.g., tadalafil, vardenafil): additive effects on blood pressure.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce sildenafil effectiveness.
• Antihypertensive agents (e.g., beta‑blockers, ACE inhibitors): monitor blood pressure response.
• Protease inhibitors (e.g., ritonavir): can increase plasma levels of sildenafil.
• Diuretics: watch for additive blood pressure effects.
• Alcohol: may enhance hypotensive response, advise moderation.